Antibody-Drug Conjugate (ADC) Drug Landscape: Historical, Current, and Emerging Therapies

Powered by

All the vital news, analysis, and commentary curated by our industry experts.

This report investigates the impacts and development of Antibody-Drug Conjugate therapies within the pharmaceutical industry from the standpoint of drug development. It provides a high-level analysis of key trends and movements within the industry via regulatory, clinical, and market-based analysis, allowing you to discern the large-scale changes within the market and how best to pivot to prioritize future changes in the market.

Scope

This 53-page report gives important, expert insight you won’t find in any other source. 28 figures throughout the report illustrate major points and trends within the Antibody- Drug Conjugate market delving deep into forecasted sales and company pipelines. This report is required reading for –

Investors that want to understand past trends impacting the Antibody- Drug Conjugate landscape as well as identifying companies to invest in

Companies that are interested in entering the Antibody- Drug Conjugate landscape and where best to focus on

Large pharma companies with investment groups or BD teams looking to see which companies lead the Antibody- Drug Conjugate landscape in the past and how they led

Small and medium pharma who want to focus their Antibody- Drug Conjugate drug portfolio on future trends and are looking for partnership opportunities

Reasons to Buy

Insights on the different types of Antibody- Drug Conjugate with current and novel forms

Insights on past trends and changes that have informed the Antibody- Drug Conjugate market

Insights on the current leading Antibody- Drug Conjugate drugs based on their Sales and Forecasts and other parameters

Therapeutic and Indication insights into the Antibody- Drug Conjugate market

Insights into the future opportunities for Antibody- Drug Conjugate and the companies leading in the market.

Pfizer
Seagen
F. Hoffmann-La Roche Ltd
Roche Holding AG
Daiichi-Sankyo Co Ltd
Abbvie Inc
Pfizer Inc
Regeneron Pharmaceuticals Inc
Gilead Sciences
Novartis AG
Bristol Myers Squibb Co
Astrazeneca Plc
Sanofi
Biocytogen Pharmaceutical Co Ltd
Hangzhou DAC Biotech Co Ltd
LigaChem Biosciences Inc
Innovent Biologics Inc
Shanghai Affinity Biopharmaceutical Co Ltd
LaNova Medicines Ltd
Genmab AS
Jiagsu Hengrui Pharmaceuticals Co Ltd
Duality Biologics Co Ltd
BioNTech SE
Remegen Co Ltd
CSPC Pharmaceutical Group Ltd
Zai Lab
Cytomx Therapeytics Inc
GSK Plc
Primelink Biotherapeutics Co Ltd
Radiopharam Theranostics
T-E Meds Inc
Neok Bio Inc
National Cancer Institute US
Hutchmed China Ltd

Table of Contents

Table of Contents (PowerPoint Deck)

1 Antibody-Drug Conjugate Introduction

1.1 Key milestones timeline

1.2 Total market sales

1.3 Point-in-time counts

2 Antibody-Drug Conjugate: Previous Years in Review

2.1 ADCs by development stage

2.2 Approvals timeline

2.3 Historical sales

2.4 Deals trends

2.5 Patents trends

2.6 Review designation trends

3 Antibody-Drug Conjugate: Current Landscape

3.1 ADCs by development stage

3.2 Top indications

3.3 Top companies

4 Antibody-Drug Conjugate: Future Outlook

4.1 Forecast sales

4.2 Top companies

4.3 Upcoming launches

5 Key Findings

6 Appendix

6.1 Abbreviations

6.2 Methodology

6.3 About the Authors

6.4 About GlobalData

6.5 Contact Us

Antibody-Drug Conjugate (ADC) Drug Landscape: Historical, Current, and Emerging Therapies thematic reports
Currency USD
$1,200

Can be used by individual purchaser only

$2,700

Can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company


Undecided about purchasing this report?

Enquire Before Buying Download FREE Resources

Get in touch to find out about multi-purchase discounts

reportstore@globaldata.com
Tel +44 20 7947 2745

Sample Report

Antibody-Drug Conjugate (ADC) Drug Landscape: Historical, Current, and Emerging Therapies was curated by the best experts in the industry and we are confident about its unique quality. However, we want you to make the most beneficial decision for your business, so we offer free sample pages to help you:

  • Assess the relevance of the report
  • Evaluate the quality of the report
  • Justify the cost

Download your copy of the sample report and make an informed decision about whether the full report will provide you with the insights and information you need.

Below is a sample report to understand what you are buying

See what our customers are saying
testimonial-image
testimonial-image
testimonial-image
testimonial-image
testimonial-image
testimonial-image
testimonial-image

“The GlobalData platform is our go-to tool for intelligence services. GlobalData provides an easy way to access comprehensive intelligence data around multiple sectors, which essentially makes it a one-for-all intelligence platform, for tendering and approaching customers.

GlobalData is very customer orientated, with a high degree of personalised services, which benefits everyday use. The highly detailed project intelligence and forecast reports can be utilised across multiple departments and workflow scopes, from operational to strategic level, and often support strategic decisions. GlobalData Analytics and visualisation solutions has contributed positively when preparing management presentations and strategic papers.”

Business Intelligence & Marketing Manager, SAL Heavy Lift

“COVID-19 has caused significant interference to our business and the COVID-19 intelligence from GlobalData has helped us reach better decisions around strategy. These two highlights have helped enormously to understand the projections into the future concerning our business units, we also utilise the project database to source new projects for Liebherr-Werk to use as an additional source to pitch for new business.”

Market Analyst & Management, Liebherr-Werk

Your daily news has saved me a lot of time and keeps me up-to-date with what is happening in the market, I like that you almost always have a link to the source origin. We also use your market data in our Strategic Business Process to support our business decisions. By having everything in one place on the Intelligence Center it has saved me a lot of time versus looking on different sources, the alert function also helps with this.

Head of Key Accounts, Saab AB

Having used several other market research companies, I find that GlobalData manages to provide that ‘difficult-to-get’ market data that others can’t, as well as very diverse and complete consumer surveys.

Marketing Intelligence Manager, Portugal Foods

Our experience with GlobalData has been very good, from the platform itself to the people. I find that the analysts and the account team have a high level of customer focus and responsiveness and therefore I can always rely on. The platform is more holistic than other providers. It is convenient and almost like a one stop shop. The pricing suite is highly competitive and value for our organisation.

I like reports that inform new segments such as the analysis on generation Z, millennials, the impact of COVID 19 to our banking customers and their new channel habits. Secondly the specialist insight on affluent sector significantly increases our understanding about this group of customers. The combination of those give us depth and breadth of the evolving market.

I’m in the business of answering and helping people make decisions so with the intelligence center I can do that, effectively and efficiently. I can share quickly key insights that answer and satisfy our country stakeholders by giving them many quality studies and primary research about competitive landscape beyond the outlook of our bank. It helps me be seen as an advisory partner and that makes a big difference. A big benefit of our subscription is that no one holds the whole data and because it allows so many people, so many different parts of our organisation have access, it enables all teams to have the same level of knowledge and decision support.

Head of Customer Insight and Research, Standard Chartered

“I know that I can always rely on Globaldata’s work when I’m searching for the right consumer and market insights. I use Globaldata insights to understand the changing market & consumer landscape and help create better taste & wellbeing solutions for our customers in food, beverage and healthcare industries.

Globaldata has the right data and the reports are of very high quality compared to your competitors. Globaldata not only has overall market sizes & consumer insights on food & beverages but also provides insights at the ingredient & flavour level. That is key for B2B companies like Givaudan. This way we understand our customers’ business and also gain insight to our unique industry”

Head of Consumer Sensory Insights, Givaudan

GlobalData provides a great range of information and reports on various sectors that is highly relevant, timely, easy to access and utilise.  The reports and data dashboards help engagement with clients; they provide valuable industry and market insights that can enrich client conversations and can help in the shaping of value propositions. Moreover, using GlobalData products has helped increase my knowledge of the finance sector, the players within it, and the general threats and opportunities.

I find the consumer surveys that are carried out to be extremely beneficial and not something I have seen anywhere else. They provided an insightful view of why and which consumers take (or don’t) particular financial products. This can help shape conversations with clients to ensure they make the right strategic decisions for their business.

One of the challenges I have found is that data in the payments space is often piecemeal. With GD all of the data I need is in one place, but it also comes with additional market reports that provide useful extra context and information. Having the ability to set-up alerts on relevant movements in the industry, be it competitors or customers, and have them emailed directly to me, ensures I get early sight of industry activity and don’t have to search for news.

Senior Account Manager, TSYS
Go even deeper with GlobalData Intelligence Center

Every Company Report we produce is powered by the GlobalData Intelligence Center.

Subscribing to our intelligence platform means you can monitor developments at Antibody-Drug Conjugate (ADC) Drug Landscape: Historical, Current, and Emerging Therapies in real time.

  • Access a live Antibody-Drug Conjugate (ADC) Drug Landscape: Historical, Current, and Emerging Therapies dashboard for 12 months, with up-to-the-minute insights.
  • Fuel your decision making with real-time deal coverage and media activity.
  • Turn insights on financials, deals, products and pipelines into powerful agents of commercial advantage.